BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21221060)

  • 1. Phage display for the generation of antibodies for proteome research, diagnostics and therapy.
    Schirrmann T; Meyer T; Schütte M; Frenzel A; Hust M
    Molecules; 2011 Jan; 16(1):412-26. PubMed ID: 21221060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage display antibodies for diagnostic applications.
    Hairul Bahara NH; Tye GJ; Choong YS; Ong EB; Ismail A; Lim TS
    Biologicals; 2013 Jul; 41(4):209-16. PubMed ID: 23647952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage display technology: clinical applications and recent innovations.
    Azzazy HM; Highsmith WE
    Clin Biochem; 2002 Sep; 35(6):425-45. PubMed ID: 12413604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations on antibody-phage display methodology.
    Conrad U; Scheller J
    Comb Chem High Throughput Screen; 2005 Mar; 8(2):117-26. PubMed ID: 15777175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Antibodies by Phage Display.
    Shim H
    Curr Pharm Des; 2016; 22(43):6538-6559. PubMed ID: 27669967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current advances in antibody-based serum biomarker studies: From protein microarray to phage display.
    Qi H; Xue JB; Lai DY; Li A; Tao SC
    Proteomics Clin Appl; 2022 Nov; 16(6):e2100098. PubMed ID: 36071670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly efficient selection of phage antibodies mediated by display of antigen as Lpp-OmpA' fusions on live bacteria.
    Benhar I; Azriel R; Nahary L; Shaky S; Berdichevsky Y; Tamarkin A; Wels W
    J Mol Biol; 2000 Aug; 301(4):893-904. PubMed ID: 10966794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody discovery: phage display.
    Kretzschmar T; von Rüden T
    Curr Opin Biotechnol; 2002 Dec; 13(6):598-602. PubMed ID: 12482520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of phage display technology: from discovery to application.
    Rahbarnia L; Farajnia S; Babaei H; Majidi J; Veisi K; Ahmadzadeh V; Akbari B
    J Drug Target; 2017 Mar; 25(3):216-224. PubMed ID: 27819143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concepts in antibody phage display.
    Carmen S; Jermutus L
    Brief Funct Genomic Proteomic; 2002 Jul; 1(2):189-203. PubMed ID: 15239904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage display of proteins.
    Dunn IS
    Curr Opin Biotechnol; 1996 Oct; 7(5):547-53. PubMed ID: 8939620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage display for detection of biological threat agents.
    Petrenko VA; Vodyanoy VJ
    J Microbiol Methods; 2003 May; 53(2):253-62. PubMed ID: 12654496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody Selection via Phage Display in Microtiter Plates.
    Steinke S; Roth KDR; Ruschig M; Langreder N; Polten S; Schneider KT; Ballmann R; Russo G; Zilkens KJK; Schubert M; Bertoglio F; Hust M
    Methods Mol Biol; 2023; 2702():247-260. PubMed ID: 37679623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophage vehicles for phage display: biology, mechanism, and application.
    Ebrahimizadeh W; Rajabibazl M
    Curr Microbiol; 2014 Aug; 69(2):109-20. PubMed ID: 24638925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for selection of antibodies by phage display.
    Griffiths AD; Duncan AR
    Curr Opin Biotechnol; 1998 Feb; 9(1):102-8. PubMed ID: 9503596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of human naive antibody gene libraries.
    Hust M; Frenzel A; Meyer T; Schirrmann T; Dübel S
    Methods Mol Biol; 2012; 907():85-107. PubMed ID: 22907347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.
    Kuhn P; Fühner V; Unkauf T; Moreira GM; Frenzel A; Miethe S; Hust M
    Proteomics Clin Appl; 2016 Oct; 10(9-10):922-948. PubMed ID: 27198131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of Human Immune and Naive scFv Phage Display Libraries.
    Ruschig M; Heine PA; Fühner V; Zilkens KJK; Steinke S; Schubert M; Bertoglio F; Hust M
    Methods Mol Biol; 2023; 2702():15-37. PubMed ID: 37679613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage display on the base of filamentous bacteriophages: application for recombinant antibodies selection.
    Tikunova NV; Morozova VV
    Acta Naturae; 2009 Oct; 1(3):20-8. PubMed ID: 22649612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.
    Roth KDR; Wenzel EV; Ruschig M; Steinke S; Langreder N; Heine PA; Schneider KT; Ballmann R; Fühner V; Kuhn P; Schirrmann T; Frenzel A; Dübel S; Schubert M; Moreira GMSG; Bertoglio F; Russo G; Hust M
    Front Cell Infect Microbiol; 2021; 11():697876. PubMed ID: 34307196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.